Literature DB >> 19298334

High-risk population for gastric cancer development based on serum pepsinogen status and lifestyle factors.

Yutaka Yamaji1, Hirotsugu Watabe, Haruhiko Yoshida, Takao Kawabe, Ryoichi Wada, Toru Mitsushima, Masao Omata.   

Abstract

BACKGROUND: Gastric atrophy is a major risk factor for non-cardiac gastric cancer. Serum pepsinogen status could identify people at high-risk for gastric cancer development during our previous cohort study. However, lifestyle-related factors may additionally affect this risk.
MATERIALS AND METHODS: A total of 6983 Japanese were followed up by annual endoscopy in the previous study, and 43 cases of gastric cancer including two cardiac cancers developed. In most subjects, the body length and weight were measured and a questionnaire was applied to gather information regarding life habits. The risk of non-cardiac gastric cancer development during surveillance was re-analyzed based on serum pepsinogen, sex, age, body mass index (BMI), alcohol, and smoking habit.
RESULTS: A total of 6158 subjects with 37 non-cardiac gastric cancer development (male/female = 4259/1899, mean age = 49.0, mean follow-up period = 4.79 years) were entered into analysis. In a multivariate analysis, old age (by 10 years; (odds ratio) OR, 2.8; p < .001), alcohol (weekly; OR, 2.4; p = .03), smoking (current; OR, 5.6; p = .006 and past; OR, 3.9; p = .04), and pepsinogen status ("atrophic"; OR, 6.2; p < .001) were independent risk factors, whereas BMI was not. The annual incidence of gastric cancer was 1.2% in the older subjects aged > or = 60 years with "atrophic" pepsinogen status. Moreover, it was as high as 2.9% when they had both alcohol and current smoking habits.
CONCLUSIONS: Old age, alcohol, and smoking habits additionally promoted the risk for gastric cancer in subjects with gastric atrophy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19298334     DOI: 10.1111/j.1523-5378.2009.00665.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  12 in total

1.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Virchows Arch       Date:  2011-12-22       Impact factor: 4.064

2.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Endoscopy       Date:  2011-12-23       Impact factor: 10.093

3.  Diverse H. pylori strains, IL-10 promoter polymorphisms with high morbidity of gastric cancer in Hexi area of Gansu Province, China.

Authors:  Xiangting Zeng; Yumin Li; Tao Liu; Junqiang Zhang
Journal:  Mol Cell Biochem       Date:  2011-11-13       Impact factor: 3.396

4.  Serum pepsinogen II is a better diagnostic marker in gastric cancer.

Authors:  Xue-Yuan Cao; Zhi-Fang Jia; Mei-Shan Jin; Dong-Hui Cao; Fei Kong; Jian Suo; Jing Jiang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

5.  Association Between Colorectal Cancer and Atherosclerotic Diseases: A Study Using a National Inpatient Database in Japan.

Authors:  Yutaka Yamaji; Hideo Yasunaga; Yoshihiro Hirata; Atsuo Yamada; Shuntaro Yoshida; Hiromasa Horiguchi; Kiyohide Fushimi; Kazuhiko Koike
Journal:  Dig Dis Sci       Date:  2016-02-01       Impact factor: 3.199

6.  Glucocorticoids and Androgens Protect From Gastric Metaplasia by Suppressing Group 2 Innate Lymphoid Cell Activation.

Authors:  Jonathan T Busada; Kylie N Peterson; Stuti Khadka; Xiaojiang Xu; Robert H Oakley; Donald N Cook; John A Cidlowski
Journal:  Gastroenterology       Date:  2021-05-07       Impact factor: 33.883

7.  Age-Specific Gastric Cancer Risk Indicated by the Combination of Helicobacter pylori Sero-Status and Serum Pepsinogen Levels.

Authors:  Sana Eybpoosh; Yeganeh Talebkhan; Samaneh Saberi; Maryam Esmaeili; Akbar Oghalaie; Fatemeh Ebrahimzadeh; Toktam Karimi; Afshin Abdirad; Azin Nahvijou; Mohammad Ali Mohagheghi; Mahmoud Eshagh Hosseini; Marjan Mohammadi
Journal:  Iran Biomed J       Date:  2015-06-28

8.  Prediction of Chronic Atrophic Gastritis and Gastric Neoplasms by Serum Pepsinogen Assay: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy.

Authors:  Chang Seok Bang; Jae Jun Lee; Gwang Ho Baik
Journal:  J Clin Med       Date:  2019-05-10       Impact factor: 4.241

Review 9.  Helicobacter pylori Antibody Titer and Gastric Cancer Screening.

Authors:  Hiroshi Kishikawa; Kayoko Kimura; Sakiko Takarabe; Shogo Kaida; Jiro Nishida
Journal:  Dis Markers       Date:  2015-09-30       Impact factor: 3.434

10.  Endoscopic gastric atrophy is strongly associated with gastric cancer development after Helicobacter pylori eradication.

Authors:  Osamu Toyoshima; Yutaka Yamaji; Shuntaro Yoshida; Shuhei Matsumoto; Hiroharu Yamashita; Takamitsu Kanazawa; Keisuke Hata
Journal:  Surg Endosc       Date:  2016-09-07       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.